Winslow Evans & Crocker Inc. cut its holdings in shares of CVS Health Corp (NYSE:CVS) by 69.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,260 shares of the pharmacy operator’s stock after selling 11,704 shares during the quarter. Winslow Evans & Crocker Inc.’s holdings in CVS Health were worth $428,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also recently made changes to their positions in CVS. Vanguard Group Inc. grew its holdings in shares of CVS Health by 1.4% in the second quarter. Vanguard Group Inc. now owns 76,557,597 shares of the pharmacy operator’s stock worth $6,159,825,000 after purchasing an additional 1,056,265 shares during the last quarter. FMR LLC grew its holdings in shares of CVS Health by 22.0% in the second quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock worth $2,425,920,000 after purchasing an additional 5,446,930 shares during the last quarter. Northern Trust Corp grew its holdings in shares of CVS Health by 5.5% in the second quarter. Northern Trust Corp now owns 15,618,081 shares of the pharmacy operator’s stock worth $1,256,631,000 after purchasing an additional 807,639 shares during the last quarter. Nordea Investment Management AB grew its holdings in shares of CVS Health by 8.4% in the second quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock worth $1,138,905,000 after purchasing an additional 1,100,373 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in CVS Health by 5.4% in the second quarter. Dimensional Fund Advisors LP now owns 10,426,282 shares of the pharmacy operator’s stock valued at $838,895,000 after acquiring an additional 534,314 shares in the last quarter. 81.62% of the stock is currently owned by hedge funds and other institutional investors.
Several research firms recently weighed in on CVS. Royal Bank of Canada began coverage on shares of CVS Health in a report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price target on the stock. Jefferies Group raised their price objective on CVS Health from $82.00 to $86.00 and gave the company a “hold” rating in a research report on Friday, September 15th. Leerink Swann raised their price objective on CVS Health from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Monday. Oppenheimer reissued a “buy” rating and set a $95.00 price objective on shares of CVS Health in a research report on Monday, October 9th. Finally, Mizuho set a $90.00 price target on CVS Health and gave the stock a “buy” rating in a research report on Tuesday, October 24th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $86.66.
Shares of CVS Health Corp (NYSE:CVS) traded down $0.24 on Friday, hitting $78.78. The stock had a trading volume of 7,098,202 shares, compared to its average volume of 10,770,000. The stock has a market cap of $79,800.00, a PE ratio of 16.28, a price-to-earnings-growth ratio of 1.38 and a beta of 0.90. CVS Health Corp has a twelve month low of $66.45 and a twelve month high of $84.72. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67.
CVS Health (NYSE:CVS) last issued its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The business had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. During the same period in the prior year, the firm earned $1.64 EPS. The company’s revenue for the quarter was up 3.5% on a year-over-year basis. analysts expect that CVS Health Corp will post 5.9 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, February 2nd. Investors of record on Wednesday, January 24th will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 23rd. This represents a $2.00 annualized dividend and a yield of 2.54%. CVS Health’s payout ratio is presently 41.32%.
In related news, EVP Lisa Bisaccia sold 29,445 shares of the stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the sale, the executive vice president now owns 15,556 shares in the company, valued at approximately $1,166,700. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.61% of the company’s stock.
About CVS Health
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.